Page last updated: 2024-12-07

2-carboxyarabinitol 1,5-biphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-Carboxyarabinitol 1,5-bisphosphate (CA1P) is a naturally occurring inhibitor of ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), the key enzyme responsible for carbon fixation in photosynthesis. It is produced by certain bacteria and algae as a mechanism to regulate their photosynthetic activity. CA1P binds to the active site of RuBisCO, blocking the entry of CO2 and inhibiting its catalytic activity. The compound is of particular interest to scientists studying photosynthesis and its regulation. Research into CA1P focuses on understanding its mechanism of action, its role in the evolution of photosynthesis, and its potential applications in bioengineering and agriculture. Some studies investigate the possibility of using CA1P as a herbicide or as a tool to enhance plant productivity.'

Cross-References

ID SourceID
PubMed CID122210
CHEBI ID41351
SCHEMBL ID65098
MeSH IDM0101856

Synonyms (17)

Synonym
2-carboxyarabinitol-1,5-diphosphate
5-o-phosphono-2-c-[(phosphonooxy)methyl]-d-ribonic acid
2-carboxyarabinitol 1,5-biphosphate
2-carboxy-d-arabinitol 1,5-bisphosphate
CHEBI:41351
2-carboxyarabinitol 1,5-bisphosphate
2-carboxy-d-arabinitol 1,5-diphosphate
27442-42-8
(2r,3r,4r)-2,3,4-trihydroxy-5-phosphonooxy-2-(phosphonooxymethyl)pentanoic acid
d-ribonic acid, 2-c-((phosphonooxy)methyl)-, 5-(dihydrogen phosphate)
2-cabp
SCHEMBL65098
DTXSID90181857
cabp
Q27104472
146758-08-9
AKOS040750980
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
ribonic acid phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (40.54)18.7374
1990's14 (37.84)18.2507
2000's4 (10.81)29.6817
2010's4 (10.81)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.82 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]